Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Eggan

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
The New England Journal of Medicine|November 29, 2013
Picking the lock on pluripotencyKevin Eggan
Cloning and Stem Cells|March 28, 2007
Dolly's legacy: human nuclear transplantation and better medicines for our childrenKevin Eggan
Regenerative Medicine|October 25, 2008
Using stem cells and reprogramming to understand diseaseKevin Eggan
Cell Stem Cell|March 29, 2008
Short-circuiting epiblast developmentKevin Eggan
Development (Cambridge, England)|May 14, 2010
Recipient cell nuclear factors are required for reprogramming by nuclear transferDieter Egli, Kevin Eggan
Seminars in Cell & Developmental Biology|March 16, 2004
Micromanipulating dosage compensation: understanding X-chromosome inactivation through nuclear transplantationKevin Eggan, Rudolf Jaenisch
Nature Neuroscience|June 27, 2013
Opportunities and challenges of pluripotent stem cell neurodegenerative disease modelsJackson Sandoe, Kevin Eggan
Methods in Enzymology|December 31, 2003
Differentiation of F1 embryonic stem cells into viable male and female mice by tetraploid embryo complementationKevin Eggan, Rudolf Jaenisch
The Journal of Clinical Investigation|January 7, 2010
Progress toward the clinical application of patient-specific pluripotent stem cellsEvangelos Kiskinis, Kevin Eggan
Journal of Visualized Experiments : Jove|August 16, 2008
Nuclear transfer into mouse oocytesDieter Egli, Kevin Eggan
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|November 29, 2013
Picking the lock on pluripotencyKevin Eggan
Cloning and Stem Cells|March 28, 2007
Dolly's legacy: human nuclear transplantation and better medicines for our childrenKevin Eggan
Regenerative Medicine|October 25, 2008
Using stem cells and reprogramming to understand diseaseKevin Eggan
Cell Stem Cell|March 29, 2008
Short-circuiting epiblast developmentKevin Eggan
Development (Cambridge, England)|May 14, 2010
Recipient cell nuclear factors are required for reprogramming by nuclear transferDieter Egli, Kevin Eggan
Seminars in Cell & Developmental Biology|March 16, 2004
Micromanipulating dosage compensation: understanding X-chromosome inactivation through nuclear transplantationKevin Eggan, Rudolf Jaenisch
Nature Neuroscience|June 27, 2013
Opportunities and challenges of pluripotent stem cell neurodegenerative disease modelsJackson Sandoe, Kevin Eggan
Methods in Enzymology|December 31, 2003
Differentiation of F1 embryonic stem cells into viable male and female mice by tetraploid embryo complementationKevin Eggan, Rudolf Jaenisch
The Journal of Clinical Investigation|January 7, 2010
Progress toward the clinical application of patient-specific pluripotent stem cellsEvangelos Kiskinis, Kevin Eggan
Journal of Visualized Experiments : Jove|August 16, 2008
Nuclear transfer into mouse oocytesDieter Egli, Kevin Eggan
Pageof 15